Traders should expect delisting from Nasdaq and a move to OTC or complete deregistration. The presence of Eli Lilly's address and only one holder of record strongly suggests the company has been acquired. Existing shareholders may have already received acquisition consideration; those holding shares should verify tender instructions or follow-up communications from the company or transfer agent.
Price Chart
Executive Summary
Ventyx Biosciences, Inc. (VTYX) has filed Form 15-12G to terminate the registration of its Common Stock under Section 12(g) of the Securities Exchange Act of 1934 and suspend its reporting obligations with the SEC. The company reports approximately one holder of record, indicating it is likely being acquired or has undergone a corporate restructuring that results in going private.
Key Facts
- Ventyx Biosciences, Inc. (VTYX) filed Form 15-12G on March 16, 2026, to terminate registration of its Common Stock under Section 12(g) of the Exchange Act.
- The company has approximately one holder of record as of the filing date, suggesting a consolidation of ownership likely due to acquisition or privatization.
- The principal executive offices are listed at Eli Lilly and Company Global Headquarters, indicating a probable acquisition by or full integration into Eli Lilly.
- No financial data is provided in the filing, but the deregistration follows a pattern typical of companies being taken private after an acquisition.
- The filing invokes Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i), which allow termination of registration when a class of security has fewer than 300 holders.
Financial Impact
The company is effectively going dark with no further public financial disclosures required. Shareholders will lose liquidity and transparency. The move suggests a completed or imminent acquisition, likely by Eli Lilly.
Risk Factors
- Loss of liquidity: Shares will no longer trade on a public exchange after delisting.
- Lack of transparency: No future 10-Ks, 10-Qs, or 8-Ks will be filed, limiting access to financial and operational updates.
- Potential for zero trading volume: With only one holder, public shareholders may have already been bought out.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001193125-26-107754 |
| Document: 0001193125-26-107754-index-headers.html | 0001193125-26-107754 |
| Document: 0001193125-26-107754-index.html | 0001193125-26-107754 |
| Document: 0001193125-26-107754.txt | 0001193125-26-107754 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 19w ago | Institutional Cluster | — | awaiting T+20 | — | — |
Mar 16, 2026 32w ago | 15-12G | — | awaiting T+20 | — | — |
Mar 9, 2026 33w ago | EFFECT | $14.00 | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers